«Back

Class 2 Recall on Magnevist And Omniscan Solutions For Injection (Various Strengths)

Class 2 Recall on Magnevist And Omniscan Solutions For Injection (Various Strengths)

All unexpired stock of the above products marketed by Bayer PLC and GE Healthcare AS is being recalled and should immediately be quarantined. This follows a safety review of the gadolinium containing contrast media by the European Medicines Agency (EMA) which has resulted in the suspension of the above licences as of 01 February 2018.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
Alliance Do Not Stock Magnevist Solution For Injection 0.5mmol/Ml (Various Strengths) Bayer Plc All Unexpired Stock
Alliance Do Not Stock Omniscan Solutions For Injection 0.5 Mmol/Ml (Various Strengths) GE Healthcare AS All Unexpired Stock

Alliance Healthcare do not stock and therefore we are not accepting stock returns.

For stock return enquiries, please contact Bayer Plc on 0118 206 3999 or email - customerservicemt@bayer.com or GE Healthcare AS on +353 87 9432162 or email - Stephen.mclaughlin2@ge.com.

For quality or medical information enquiries, please contact Bayer Plc on 0118 206 3116 or email - medical.information@bayer.co.uk or GE Healthcare AS on 0149 4544 000 or email - Medical.Information@ge.com .

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.